#paxlovid

[ follow ]

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

Paxlovid may benefit some long Covid patients, but results vary significantly and the underlying causes remain unclear.
#covid-19

Joe Biden is taking Paxlovid, even though doctors know it doesn't really work

President Biden tested positive for COVID and is taking the antiviral drug Paxlovid, which recent studies suggest may have limited effectiveness.

Many People Are Eligible for Paxlovid. Who Should Take It?

Most adults in the U.S. are eligible for Paxlovid, but confusion and lack of provider experience limit its prescription despite proven benefits.

Gov. Mike DeWine tests positive for COVID amid summer surge

Ohio Governor Mike DeWine tests positive for COVID-19 and works from home as cases rise.

'Lifesaver' anti-viral Covid medicine might no longer be needed, says HSE

Paxlovid is advised against for prescription, indicating diminished utility in treating Covid-19.

'Lifesaver' anti-viral Covid medicine might no longer be needed, says HSE

Paxlovid is now considered to have little benefit for treating Covid-19 according to an unpublished HSE proposal.

Why COVID patients who could most benefit from Paxlovid still aren't getting it

Paxlovid's high cost is a barrier to access for many patients.
Awareness of Paxlovid's benefits and free access programs is low.

Joe Biden is taking Paxlovid, even though doctors know it doesn't really work

President Biden tested positive for COVID and is taking the antiviral drug Paxlovid, which recent studies suggest may have limited effectiveness.

Many People Are Eligible for Paxlovid. Who Should Take It?

Most adults in the U.S. are eligible for Paxlovid, but confusion and lack of provider experience limit its prescription despite proven benefits.

Gov. Mike DeWine tests positive for COVID amid summer surge

Ohio Governor Mike DeWine tests positive for COVID-19 and works from home as cases rise.

'Lifesaver' anti-viral Covid medicine might no longer be needed, says HSE

Paxlovid is advised against for prescription, indicating diminished utility in treating Covid-19.

'Lifesaver' anti-viral Covid medicine might no longer be needed, says HSE

Paxlovid is now considered to have little benefit for treating Covid-19 according to an unpublished HSE proposal.

Why COVID patients who could most benefit from Paxlovid still aren't getting it

Paxlovid's high cost is a barrier to access for many patients.
Awareness of Paxlovid's benefits and free access programs is low.
morecovid-19

Paxlovid COVID Treatment Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It

Paxlovid was widely used for COVID treatment but may not be as effective in all cases, particularly for those at low or moderate risk of severe infection.
#covid-19-treatment

Why COVID patients who could most benefit from Paxlovid still aren't getting it

The high cost of Paxlovid is a barrier to access for many patients.
Low awareness among patients and doctors about Paxlovid's benefits and application process.

Exclusive: Biden admin officials push pharmacy execs on Paxlovid costs

The Biden administration is urging pharmacy chains to provide accurate information about the cost of the COVID-19 treatment Paxlovid.
Patients have sometimes been charged the full list price of $1,400 for Paxlovid, leading to low uptake of the medication.

Why COVID patients who could most benefit from Paxlovid still aren't getting it

The high cost of Paxlovid is a barrier to access for many patients.
Low awareness among patients and doctors about Paxlovid's benefits and application process.

Exclusive: Biden admin officials push pharmacy execs on Paxlovid costs

The Biden administration is urging pharmacy chains to provide accurate information about the cost of the COVID-19 treatment Paxlovid.
Patients have sometimes been charged the full list price of $1,400 for Paxlovid, leading to low uptake of the medication.
morecovid-19-treatment

Ex-Pfizer Employee Convicted for Insider Trades Ahead of Positive Paxlovid Data

A former Pfizer employee has been convicted of insider trading after buying options in the company's stock prior to the announcement of positive Covid-19 drug data.
The employee, Amit Dagar, was a senior statistical program lead for the clinical trial of Pfizer's drug Paxlovid, which showed an 89% reduction in hospitalization or death compared to a placebo.
[ Load more ]